IgA nephropathy (IgAN) is recurrent after transplantation; however, its time of recurrence is unpredictable. To date, factors influencing IgAN recurrence have not been elucidated. We present a case of a 23‐year‐old man with end‐stage renal disease (ESRD) who underwent living‐related ABO‐identical pre‐emptive kidney transplantation (PEKT) using his 57‐year‐old mother as a donor. IgAN started when the patient was 19 years old, and renal biopsy revealed the usual pathological findings of IgAN. In spite of steroid therapy including steroid pulse and tonsillectomy, the patient developed nephrotic syndrome and progressed to ESRD in 4 years. Protocol biopsy on day 19 following PEKT revealed active recurrent IgAN. Nephrotic‐range proteinuria and mild deterioration of kidney function developed regardless of strong immunosuppressive therapy such as steroid pulse, double filtration plasmapheresis and rituximab. We report a case of refractory IgAN that recurred 19 days after transplantation. This case is considered of value to elucidate factors leading to active IgAN recurrence.
1 January 2020 in Clinical Nephrology – Case Studies
Dense deposit disease (DDD), a subtype of complement component 3 (C3) glomerulopathy (C3G), results from alternative complement pathway hyperactivity leading to membrane attack complex formation. DDD treatment strategies are limited. We report a case of a 13-year-old girl diagnosed with DDD at 9 years of age, with nephritic and nephrotic syndrome and C3 nephritic factor-negative alternative complement pathway activation. Initial treatment with prednisolone, methylprednisolone pulses (MPs), and mizoribines was effective for 3 years, after which she relapsed. Despite MP treatment followed by prednisolone and mycophenolate mofetil (MMF), her kidney function and proteinuria deteriorated with a high soluble (s)C5b-9 level; she also developed dyspnea and pleural effusion (PE). Three days after the first eculizumab (ECZ) infusion, urine volume increased, respiratory condition improved, PE resolved, and proteinuria decreased in 1 month. Serum creatinine level decreased, and kidney function completely normalized within 7 weeks. The sC5b-9 level normalized, and although proteinuria decreased, nephrotic range proteinuria persisted during ECZ treatment with MMF for 53 weeks, even with increased treatment interval. Thus, complement activation pathway-targeted therapy may be useful for rapidly progressing DDD. Our data support the role of complement pathway abnormalities in C3G with DDD.
1 November 1997 in Clinical and Experimental Nephrology
Due to economic shocks related to the COVID-19 pandemic, micro, small, and medium-sized enterprises (MSMEs) have faced significant hardship. Questions arise; however, regarding the extent to which hardship has varied between sectors and countries over time, whether it is gender neutral, whether digitalization could alleviate it, and whether government support has reached them. Using survey data from eight Asian countries, we found a wide variation in the severity of and responses to the pandemic impacts between sectors and between countries. Turning to common trends, firstly, MSMEs’ sales and non-permanent employment tended to recover toward late 2020. Second, women-led enterprises remained vulnerable, exhibiting bleak prospects for sales or more job cuts than men-led enterprises. Third, the intensity of digitalization had a nonlinear relationship with sales and employment. Lastly, the number of MSMEs receiving support from their governments increased, but such support could have more effectively reached the most vulnerable MSMEs.
20 March 2021 in Clinical and Experimental Nephrology
Background Pathological findings in Alport syndrome frequently show mesangial proliferation and sometimes incidental IgA deposition, in addition to unique glomerular basement membrane (GBM) changes including thin basement membrane and/or lamellation. However, similar GBM abnormalities are also often observed in IgA nephropathy. Both diseases are also known to show hematuria, proteinuria, and sometimes macrohematuria when associated with viral infection. Therefore, it can be difficult to make a differential diagnosis, even based on clinical and pathological findings. Some recent articles demonstrated that galactose-deficient IgA1 (Gd-IgA1)-specific monoclonal antibody (KM55) could potentially enable incidental IgA deposition to be distinguished from IgA nephropathy. Methods We performed comprehensive gene screening and glomerular Gd-IgA1 and type IV collagen α5 chain immunostaining for five cases with both IgA deposition and GBM changes to confirm that Gd-IgA1 can help to distinguish these two diseases. Results Four of the cases were genetically diagnosed with Alport syndrome (Cases 1–4) and one was IgA nephropathy with massive GBM changes, which had a negative gene test result (Case 5). In Cases 1–4, glomerular Gd-IgA1 deposition was not detected, although there was positivity for IgA in the mesangial area. In Case 5, glomerular Gd-IgA1 deposition was observed. Conclusion Gd-IgA1 expression analysis could clearly differentiate these two disorders. This approach can be applied to identify these two diseases showing identical clinical and pathological findings.
This paper examines structural transformation in the formal and informal sectors by developing a decomposition framework for aggregate employment transitions and productivity changes across these sectors. We use novel micro-level data on formal and informal firms from the Economic Census of Cambodia in 2011 and 2022. We find that aggregate employment increased by 78.1%, with the formal sector accounting for 70.9% and the informal sector for 7.2% of this growth. The aggregate share of formal employment increased by 20.7 percentage points, primarily driven by within-industry increases in formal employment. Aggregate productivity—measured as value added per worker—increased by 103%, with a contribution of 71.5% from the formal sector. Within-industry productivity growth is key to productivity gains in both formal and informal sectors, while employment reallocation from informal to formal firms also yields productivity gains. Thus, the growth of formal firms is key to structural transformation and economic growth.